Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: First national administration Med̈ller tiroid kanserli bir olguda inoperabl karaciǧer metastazlarinin Yttrium-90 (Y-90) işaretli mikroküreler ile selektif intraarteriyel radyon̈klid tedavisi: Ilk ulusal uygulama
Gulhane Medical Journal, cilt.54, sa.1, ss.57-61, 2012 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 54 Sayı: 1
- Basım Tarihi: 2012
- Dergi Adı: Gulhane Medical Journal
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.57-61
- Anahtar Kelimeler: Liver tumor, Radiomicrosphere, Selective intra-arterial radionuclide therapy, Yittrium-90
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIR-Spheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented. © Gülhane Askeri Ti{dotless}p Akademisi 2012.